10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,569 | -53.7% | 62,311 | -37.3% | 0.00% | -57.1% |
| Q2 2023 | $5,552 | +0.9% | 99,452 | +0.8% | 0.01% | 0.0% |
| Q1 2023 | $5,501 | +52.7% | 98,614 | -0.3% | 0.01% | +40.0% |
| Q4 2022 | $3,603 | -99.9% | 98,883 | -25.9% | 0.01% | -16.7% |
| Q3 2022 | $3,801,000 | -33.9% | 133,468 | +5.0% | 0.01% | -25.0% |
| Q2 2022 | $5,750,000 | +8.3% | 127,075 | +82.1% | 0.01% | +33.3% |
| Q1 2022 | $5,308,000 | -33.1% | 69,784 | +31.1% | 0.01% | -25.0% |
| Q4 2021 | $7,929,000 | +111.0% | 53,234 | +106.3% | 0.01% | +100.0% |
| Q3 2021 | $3,757,000 | -22.0% | 25,809 | +4.9% | 0.00% | -20.0% |
| Q2 2021 | $4,816,000 | +7926.7% | 24,597 | +7308.7% | 0.01% | – |
| Q1 2021 | $60,000 | +36.4% | 332 | +5.1% | 0.00% | – |
| Q4 2020 | $44,000 | – | 316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |